11,854 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by Silver Oak Securities Incorporated

Silver Oak Securities Incorporated bought a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor bought 11,854 shares of the pharmacy operator’s stock, valued at approximately $110,000.

Several other large investors also recently added to or reduced their stakes in the business. Brooklyn Investment Group boosted its position in Walgreens Boots Alliance by 21.1% during the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after purchasing an additional 830 shares during the period. First Financial Corp IN boosted its holdings in shares of Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares during the period. Sequoia Financial Advisors LLC grew its stake in Walgreens Boots Alliance by 4.4% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock valued at $226,000 after buying an additional 1,063 shares during the last quarter. Lincluden Management Ltd. raised its holdings in Walgreens Boots Alliance by 0.4% in the 3rd quarter. Lincluden Management Ltd. now owns 264,644 shares of the pharmacy operator’s stock worth $2,371,000 after acquiring an additional 1,074 shares during the period. Finally, CWA Asset Management Group LLC lifted its position in Walgreens Boots Alliance by 9.2% during the 4th quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock worth $120,000 after acquiring an additional 1,084 shares during the last quarter. 58.59% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. UBS Group raised their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Bank of America lifted their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. TD Cowen cut their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. Jefferies Financial Group lowered their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Finally, Royal Bank of Canada upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and an average price target of $13.19.

Read Our Latest Report on Walgreens Boots Alliance

Walgreens Boots Alliance Stock Performance

NASDAQ WBA opened at $10.12 on Monday. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.96. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The stock has a market cap of $8.75 billion, a P/E ratio of -0.99, a PEG ratio of 1.26 and a beta of 0.65. The company’s 50-day simple moving average is $10.22 and its 200 day simple moving average is $9.81.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company’s revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.66 EPS. As a group, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.